Ankylosing spondylitis: when biologics change everything
TNF inhibitors revolutionised AS management. For patients with persistent, debilitating symptoms the benefit greatly outweighs the risk.
Ankylosing spondylitis, back pain, osteoporosis and other musculoskeletal conditions explained.
TNF inhibitors revolutionised AS management. For patients with persistent, debilitating symptoms the benefit greatly outweighs the risk.
Pain worse with rest and morning stiffness points to inflammation; pain with movement points to mechanical causes. Why the difference decides treatment.
The greatest risk of another osteoporotic fracture is having already had one. A simple fracture liaison service cuts re-fractures by 80%.